Filtered By:
Condition: Stroke
Management: Centers for Disease Control and Prevention (CDC)
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 251 results found since Jan 2013.
Consumer Health: Recovering from a stroke
May is National Stroke Awareness Month, which makes this a good time to learn more about recovering from a stroke with stroke rehabilitation. Stroke is one of the leading causes of death in the U.S. and a major cause of serious disability for adults. More than 795,000 people in the U.S. have a stroke each year, according to the Centers for Disease Control and Prevention. Stroke risk increases with age, especially after 55, but strokes can occur at…
Source: News from Mayo Clinic - May 30, 2022 Category: Databases & Libraries Source Type: news
Mayo Clinic Q & amp;A podcast: Don't ignore the warning signs of stroke
On average, someone in the U.S. has a stroke every 40 seconds, according to the Centers for Disease Control and Prevention. A stroke is a medical emergency, and prompt treatment is crucial. Early action can reduce brain damage and other complications. A stroke occurs when the blood supply to part of the brain is interrupted, depriving the brain of oxygen. It's important to recognize the warning signs of stroke, because prompt treatment can minimize brain damage. Every…
Source: News from Mayo Clinic - May 24, 2022 Category: Databases & Libraries Source Type: news
New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition (DPI) with XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD)
RARITAN, N.J., May 23, 2022 – Findings from the XARELTO® (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and the XARELTO® in Combination with Acetylsalicylic Acid (XATOA) registry have been published in the European Society of Cardiology’s (ESC) European Heart Journal, Cardiovascular Pharmacotherapy. Additionally, the XATOA registry was presented at the American Congress of Cardiology’s 71st Annual Scientific Session (ACC.22). These studies provide further evidence supporting the role of dual pathway inhibition (DPI) with the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 100 mg...
Source: Johnson and Johnson - May 23, 2022 Category: Pharmaceuticals Source Type: news
Consumer Health: Do you know the warning signs of stroke?
May is National Stroke Awareness Month, which makes this a good time to learn about the warning signs of stroke and the need for prompt treatment. Stroke is one of the leading causes of death in the U.S. and a major cause of serious disability for adults. More than 795,000 people in the U.S. have a stroke each year, according to the Centers for Disease Control and Prevention. Stroke risk increases with age, especially after 55, but strokes…
Source: News from Mayo Clinic - May 3, 2022 Category: Databases & Libraries Source Type: news
What the Science Says About the Health Benefits of Vitamins and Supplements
From multivitamins and melatonin to fiber and fish oil, Americans who are trying to boost their health and immunity have a plethora of supplements to choose from. An estimated 58% of U.S. adults ages 20 and over take dietary supplements, according to the U.S. Centers for Disease Control and Prevention, and the supplement industry is valued at more than $30 billion a year. Supplement use has been growing rapidly over the past few decades along with the wellness industry.
“The popular belief is that a supplement is going to be helpful for promoting health,” says Fang Fang Zhang, a professor at Tufts University&rs...
Source: TIME: Health - April 28, 2022 Category: Consumer Health News Authors: Sandeep Ravindran Tags: Uncategorized Diet & Nutrition healthscienceclimate Source Type: news
COVID-19, Overdoses Made 2021 The Deadliest Year in U.S. History
2021 was the deadliest year in U.S. history, and new data and research are offering more insights into how it got that bad.
The main reason for the increase in deaths? COVID-19, said Robert Anderson, who oversees the Centers for Disease Control and Prevention’s work on death statistics.
The agency this month quietly updated its provisional death tally. It showed there were 3.465 million deaths last year, or about 80,000 more than 2020’s record-setting total.
Early last year, some experts were optimistic that 2021 would not be as bad as the first year of the pandemic — partly because effective COVID-19 vac...
Source: TIME: Health - April 12, 2022 Category: Consumer Health News Authors: MIKE STOBBE / AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news
Flinn Foundation commits $5.52M to College of Medicine – Phoenix
The gift will establish two research faculty positions and support training to further translational research in cardiovascular diseases, neurosciences and mental health.
April 7, 2022
University Alumni and Development Programflinn-gift-web.jpg
Lauren MacDonnell, a research associate in the Translational Cardiovascular Research Center, processes samples in the TCRC lab.
Sun Belous/College of Medicine – Phoenix Marketing and CommunicationsHealthCollege of Medicine - PhoenixCollege of PharmacyCompassion
Media contact(s)Beth Smith
College of Medicine – Phoenixbhsmith1@arizona.edu602-827-2676TheFlinn Foundation has...
Source: The University of Arizona: Health - April 6, 2022 Category: Universities & Medical Training Authors: mittank Source Type: research
New Janssen Initiative Aims to Advance Equitable Care and Address Hidden Threat of Amputation Related to Peripheral Artery Disease (PAD)
TITUSVILLE, N.J., March 31, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the launch of Save Legs. Change Lives.™ Spot Peripheral Artery Disease Now, a multi-year initiative aimed at creating urgency and action to address the hidden threat of peripheral artery disease (PAD)-related amputation, with an initial focus on reaching Black Americans, who are more than twice as likely to be impacted by PAD.1 Janssen has joined forces with leading professional associations, healthcare systems and community organizations to advance equitable care for individuals and communities placed at an...
Source: Johnson and Johnson - March 31, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Proceedings From a National Heart, Lung, and Blood Institute and the Centers for Disease Control and Prevention Workshop to Control Hypertension
Am J Hypertens. 2022 Mar 8;35(3):232-243. doi: 10.1093/ajh/hpab182.ABSTRACTHypertension treatment and control prevent more cardiovascular events than management of other modifiable risk factors. Although the age-adjusted proportion of US adults with controlled blood pressure (BP) defined as <140/90 mm Hg, improved from 31.8% in 1999-2000 to 48.5% in 2007-2008, it remained stable through 2013-2014 and declined to 43.7% in 2017-2018. To address the rapid decline in hypertension control, the National Heart, Lung, and Blood Institute and the Division for Heart Disease and Stroke Prevention of the Centers for Disease Control...
Source: American Journal of Hypertension - March 8, 2022 Category: Cardiology Authors: Yvonne Commodore-Mensah Fleetwood Loustalot Cheryl Dennison Himmelfarb Patrice Desvigne-Nickens Vandana Sachdev Kirsten Bibbins-Domingo Steven B Clauser Deborah J Cohen Brent M Egan A Mark Fendrick Keith C Ferdinand Cliff Goodman Garth N Graham Marc G Jaf Source Type: research
